Zhihao Liu

Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2

Zhihao Liu, Xi Hu, Qiwei Wang et al. · Journal of Medicinal Chemistry · 2021 · 116 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect

Qian Lei, Lu Xiong, Yong Xia et al. · Cell Death and Disease · 2018 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results

Zhihao Liu, Y Zhang, Haowen Xiao et al. · Bone Marrow Transplantation · 2017 · 63 citations

Medicine, Hematology, Translational Sciences +17

Discovery of Imidazo[2,1-<i>b</i>]thiazole HCV NS4B Inhibitors Exhibiting Synergistic Effect with Other Direct-Acting Antiviral Agents

Ningyu Wang, Ying Xu, Weiqiong Zuo et al. · Journal of Medicinal Chemistry · 2015 · 43 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis

Tiantao Gao, Quanfang Hu, Xi Hu et al. · Cancer Letters · 2018 · 43 citations

Medicine, Oncology, Pharmacology +10